{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:03:53Z","timestamp":1793498633216,"version":"4.5.0"},"publisher-location":"Cham","reference-count":84,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319425405","type":"print"},{"value":"9783319425429","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-3-319-42542-9_8","type":"book-chapter","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T04:10:41Z","timestamp":1480565441000},"page":"137-153","source":"Crossref","is-referenced-by-count":33,"title":["Obesity and Prostate Cancer"],"prefix":"10.1007","author":[{"given":"Yin","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Giovannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"key":"8_CR1","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F (2013) GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide. IARC CancerBase No. 11. IARC Press, Lyon"},{"key":"8_CR2","unstructured":"Cancer Facts & Figures\u00a02015 (2015). American Cancer Society, Atlanta"},{"issue":"6","key":"8_CR3","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/cncr.11212","volume":"97","author":"KC Chu","year":"2003","unstructured":"Chu KC, Tarone RE, Freeman HP (2003) Trends in prostate cancer mortality among black men and white men in the United States. Cancer 97(6):1507\u20131516. doi: 10.1002\/cncr.11212","journal-title":"Cancer"},{"issue":"12","key":"8_CR4","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1002\/ijc.29408","volume":"137","author":"JL Jahn","year":"2015","unstructured":"Jahn JL, Giovannucci EL, Stampfer MJ (2015) The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era. Int J Cancer J Int Cancer 137(12):2795\u20132802. doi: 10.1002\/ijc.29408","journal-title":"Int J Cancer J Int Cancer"},{"issue":"7","key":"8_CR5","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/ijc.22788","volume":"121","author":"E Giovannucci","year":"2007","unstructured":"Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC (2007) Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer J Int Cancer 121(7):1571\u20131578. doi: 10.1002\/ijc.22788","journal-title":"Int J Cancer J Int Cancer"},{"issue":"4","key":"8_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1158\/1940-6207.CAPR-10-0229","volume":"4","author":"Y Cao","year":"2011","unstructured":"Cao Y, Ma J (2011) Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila) 4(4):486\u2013501. doi: 10.1158\/1940-6207.CAPR-10-0229","journal-title":"Cancer Prev Res (Phila)"},{"issue":"7","key":"8_CR7","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/annonc\/mdr603","volume":"23","author":"A Discacciati","year":"2012","unstructured":"Discacciati A, Orsini N, Wolk A (2012) Body mass index and incidence of localized and advanced prostate cancer\u2014a dose-response meta-analysis of prospective studies. Ann Oncol (Official Journal of the European Society for Medical Oncology\/ESMO) 23(7):1665\u20131671. doi: 10.1093\/annonc\/mdr603","journal-title":"Ann Oncol (Official Journal of the European Society for Medical Oncology\/ESMO)"},{"issue":"8","key":"8_CR8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s10552-006-0049-z","volume":"17","author":"RJ MacInnis","year":"2006","unstructured":"MacInnis RJ, English DR (2006) Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control (CCC) 17(8):989\u20131003. doi: 10.1007\/s10552-006-0049-z","journal-title":"Cancer Causes Control (CCC)"},{"issue":"9612","key":"8_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569\u2013578. doi: 10.1016\/S0140-6736(08)60269-X","journal-title":"Lancet"},{"issue":"5","key":"8_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/aje\/kwv089","volume":"182","author":"JH Fowke","year":"2015","unstructured":"Fowke JH, McLerran DF, Gupta PC, He J, Shu XO, Ramadas K, Tsugane S, Inoue M, Tamakoshi A, Koh WP, Nishino Y, Tsuji I, Ozasa K, Yuan JM, Tanaka H, Ahn YO, Chen CJ, Sugawara Y, Yoo KY, Ahsan H, Pan WH, Pednekar M, Gu D, Xiang YB, Sauvaget C, Sawada N, Wang R, Kakizaki M, Tomata Y, Ohishi W, Butler LM, Oze I, Kim DH, You SL, Park SK, Parvez F, Chuang SY, Chen Y, Lee JE, Grant E, Rolland B, Thornquist M, Feng Z, Zheng W, Boffetta P, Sinha R, Kang D, Potter JD (2015) Associations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium. Am J Epidemiol 182(5):381\u2013389. doi: 10.1093\/aje\/kwv089","journal-title":"Am J Epidemiol"},{"issue":"6","key":"8_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1054\/bjoc.2000.1355","volume":"83","author":"SJ Chia","year":"2000","unstructured":"Chia SJ, Tang WY, Elnatan J, Yap WM, Goh HS, Smith DR (2000) Prostate tumours from an Asian population: examination of bax, bcl-2, p53 and ras and identification of bax as a prognostic marker. Br J Cancer 83(6):761\u2013768. doi: 10.1054\/bjoc.2000.1355","journal-title":"Br J Cancer"},{"issue":"4","key":"8_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1158\/1940-6207.CAPR-10-0257","volume":"4","author":"CE Joshu","year":"2011","unstructured":"Joshu CE, Mondul AM, Menke A, Meinhold C, Han M, Humphreys EB, Freedland SJ, Walsh PC, Platz EA (2011) Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prev Res (Phila) 4(4):544\u2013551. doi: 10.1158\/1940-6207.CAPR-10-0257","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"8_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/pcan.2012.32","volume":"16","author":"R Asmar","year":"2013","unstructured":"Asmar R, Beebe-Dimmer JL, Korgavkar K, Keele GR, Cooney KA (2013) Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis 16(1):62\u201366. doi: 10.1038\/pcan.2012.32","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"8_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.juro.2013.09.065","volume":"191","author":"JJ Tomaszewski","year":"2014","unstructured":"Tomaszewski JJ, Richman EL, Sadetsky N, O\u2019Keefe DS, Carroll PR, Davies BJ, Chan JM (2014) Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE. J Urol 191(4):971\u2013976. doi: 10.1016\/j.juro.2013.09.065","journal-title":"J Urol"},{"key":"8_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29842","author":"E Moller","year":"2015","unstructured":"Moller E, Wilson KM, Batista JL, Mucci LA, Balter K, Giovannucci E (2015) Body size across the life course and prostate cancer in the health professionals follow-up study. Int J Cancer J Int Cancer. doi: 10.1002\/ijc.29842","journal-title":"Int J Cancer J Int Cancer"},{"issue":"3","key":"8_CR16","doi-asserted-by":"crossref","first-page":"s843","DOI":"10.1093\/ajcn\/86.3.843S","volume":"86","author":"AW Hsing","year":"2007","unstructured":"Hsing AW, Sakoda LC, Chua S Jr (2007) Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 86(3):s843\u2013s857","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"8_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/BF03346748","volume":"36","author":"K Esposito","year":"2013","unstructured":"Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Parretta E, Lenzi A, Giugliano D (2013) Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis. J Endocrinol Invest 36(2):132\u2013139. doi: 10.1007\/BF03346748","journal-title":"J Endocrinol Invest"},{"key":"8_CR18","doi-asserted-by":"publisher","unstructured":"Pischon T, Boeing H, Weikert S, Allen N, Key T, Johnsen NF, Tjonneland A, Severinsen MT, Overvad K, Rohrmann S, Kaaks R, Trichopoulou A, Zoi G, Trichopoulos D, Pala V, Palli D, Tumino R, Sacerdote C, Bueno-De-Mesquita HB, May A, Manjer J, Wallstrom P, Stattin P, Hallmans G, Buckland G, Larranaga N, Chirlaque MD, Martinez C, Cornejo MLR, Ardanaz E, Bingham S, Khaw KT, Rinaldi S, Slimani N, Jenab M, Riboli E (2008) Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidem Biomar 17(11):3252\u20133261. doi: 10.1158\/1055-9965.Epi-08-0609","DOI":"10.1158\/1055-9965.Epi-08-0609"},{"issue":"12","key":"8_CR19","first-page":"1417","volume":"12","author":"RJ MacInnis","year":"2003","unstructured":"MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG (2003) Body size and composition and prostate cancer risk. Cancer Epidem Biomar 12(12):1417\u20131421","journal-title":"Cancer Epidem Biomar"},{"issue":"5","key":"8_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ejca.2015.01.003","volume":"51","author":"K Ohwaki","year":"2015","unstructured":"Ohwaki K, Endo F, Hattori K (2015) Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomy. Eur J Cancer 51(5):604\u2013609. doi: 10.1016\/j.ejca.2015.01.003","journal-title":"Eur J Cancer"},{"key":"8_CR21","doi-asserted-by":"publisher","unstructured":"Keum N, Greenwood DC, Lee DH, Kim R, Aune D, Ju W, Hu FB, Giovannucci EL (2015) Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst 107(2). doi: 10.1093\/jnci\/djv088","DOI":"10.1093\/jnci\/djv088"},{"issue":"8","key":"8_CR22","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s10552-014-0393-3","volume":"25","author":"SE Bonn","year":"2014","unstructured":"Bonn SE, Wiklund F, Sjolander A, Szulkin R, Stattin P, Holmberg E, Gronberg H, Balter K (2014) Body mass index and weight change in men with prostate cancer: progression and mortality. Cancer Causes Control (CCC) 25(8):933\u2013943. doi: 10.1007\/s10552-014-0393-3","journal-title":"Cancer Causes Control (CCC)"},{"key":"8_CR23","doi-asserted-by":"publisher","unstructured":"Sutcliffe S, Colditz GA (2013) Prostate cancer: is it time to expand the research focus to early-life exposures? Nat Rev Cancer 13(3):208\u2013518. doi: 10.1038\/nrc3434","DOI":"10.1038\/nrc3434"},{"issue":"11","key":"8_CR24","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/aje\/kwm013","volume":"165","author":"AJ Littman","year":"2007","unstructured":"Littman AJ, White E, Kristal AR (2007) Anthropometrics and prostate cancer risk. Am J Epidemiol 165(11):1271\u20131279. doi: 10.1093\/aje\/kwm013","journal-title":"Am J Epidemiol"},{"issue":"7","key":"8_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/bjc.2011.319","volume":"105","author":"A Discacciati","year":"2011","unstructured":"Discacciati A, Orsini N, Andersson SO, Andren O, Johansson JE, Wolk A (2011) Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study. Br J Cancer 105(7):1061\u20131068. doi: 10.1038\/bjc.2011.319","journal-title":"Br J Cancer"},{"issue":"16","key":"8_CR26","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/djg009","volume":"95","author":"E Giovannucci","year":"2003","unstructured":"Giovannucci E, Rimm EB, Liu Y, Leitzmann M, Wu K, Stampfer MJ, Willett WC (2003) Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst 95(16):1240\u20131244","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"8_CR27","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/aje\/kwi150","volume":"161","author":"WR Robinson","year":"2005","unstructured":"Robinson WR, Stevens J, Gammon MD, John EM (2005) Obesity before age 30\u00a0years and risk of advanced prostate cancer. Am J Epidemiol 161(12):1107\u20131114. doi: 10.1093\/aje\/kwi150","journal-title":"Am J Epidemiol"},{"issue":"6","key":"8_CR28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/oxfordjournals.aje.a010241","volume":"151","author":"AG Schuurman","year":"2000","unstructured":"Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA (2000) Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 151(6):541\u2013549","journal-title":"Am J Epidemiol"},{"issue":"1","key":"8_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.urology.2007.09.065","volume":"72","author":"M Barba","year":"2008","unstructured":"Barba M, Terrenato I, Schunemann HJ, Fuhrman B, Sperati F, Teter B, Gallucci M, D\u2019Amato A, Muti P (2008) Indicators of sexual and somatic development and adolescent body size in relation to prostate cancer risk: results from a case-control study. Urology 72(1):183\u2013187. doi: 10.1016\/j.urology.2007.09.065","journal-title":"Urology"},{"issue":"8","key":"8_CR30","first-page":"557","volume":"6","author":"E Giovannucci","year":"1997","unstructured":"Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1997) Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 6(8):557\u2013563","journal-title":"Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)"},{"issue":"1","key":"8_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/bjc.2014.266","volume":"111","author":"J Aarestrup","year":"2014","unstructured":"Aarestrup J, Gamborg M, Cook MB, Sorensen TI, Baker JL (2014) Childhood body mass index and the risk of prostate cancer in adult men. Br J Cancer 111(1):207\u2013212. doi: 10.1038\/bjc.2014.266","journal-title":"Br J Cancer"},{"issue":"12","key":"8_CR32","first-page":"1335","volume":"9","author":"AW Hsing","year":"2000","unstructured":"Hsing AW, Deng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Benichou J, Xie T, Gao YT (2000) Body size and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 9(12):1335\u20131341","journal-title":"Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)"},{"key":"8_CR33","doi-asserted-by":"publisher","first-page":"691380","DOI":"10.1155\/2012\/691380","volume":"2012","author":"J Li","year":"2012","unstructured":"Li J, Djenaba JA, Soman A, Rim SH, Master VA (2012) Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001\u20132007. Prostate Cancer 2012:691380. doi: 10.1155\/2012\/691380","journal-title":"Prostate Cancer"},{"issue":"4 Suppl","key":"8_CR34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1353\/hpu.2007.0114","volume":"18","author":"JA Satia","year":"2007","unstructured":"Satia JA, Galanko JA (2007) Demographic, behavioral, psychosocial, and dietary correlates of cancer screening in African Americans. J Health Care Poor Underserved 18(4 Suppl):146\u2013164","journal-title":"J Health Care Poor Underserved"},{"key":"8_CR35","doi-asserted-by":"publisher","unstructured":"Freedland SJ, Platz EA, Presti JC Jr, Aronson WJ, Amling CL, Kane CJ, Terris MK (2006) Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol 175(2):500\u2013504; discussion 504. doi: 10.1016\/S0022-5347(05)00162-X","DOI":"10.1016\/S0022-5347(05)00162-X"},{"issue":"19","key":"8_CR36","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.298.19.2275","volume":"298","author":"LL Banez","year":"2007","unstructured":"Banez LL, Hamilton RJ, Partin AW, Vollmer RT, Sun L, Rodriguez C, Wang Y, Terris MK, Aronson WJ, Presti JC Jr, Kane CJ, Amling CL, Moul JW, Freedland SJ (2007) Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 298(19):2275\u20132280. doi: 10.1001\/jama.298.19.2275","journal-title":"JAMA"},{"issue":"3","key":"8_CR37","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1158\/1055-9965.EPI-08-0938","volume":"18","author":"RL Grubb 3rd","year":"2009","unstructured":"Grubb RL 3rd, Black A, Izmirlian G, Hickey TP, Pinsky PF, Mabie JE, Riley TL, Ragard LR, Prorok PC, Berg CD, Crawford ED, Church TR, Andriole GL Jr, Team PP (2009) Serum prostate-specific antigen hemodilution among obese men undergoing screening in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 18(3):748\u2013751. doi: 10.1158\/1055-9965.EPI-08-0938","journal-title":"Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)"},{"issue":"4","key":"8_CR38","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/cncr.22443","volume":"109","author":"ME Wright","year":"2007","unstructured":"Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T, Hurwitz P, Hollenbeck A, Leitzmann MF (2007) Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109(4):675\u2013684. doi: 10.1002\/cncr.22443","journal-title":"Cancer"},{"issue":"11","key":"8_CR39","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S1470-2045(08)70235-3","volume":"9","author":"J Ma","year":"2008","unstructured":"Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL, Gaziano JM, Pollak M, Stampfer MJ (2008) Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol 9(11):1039\u20131047. doi: 10.1016\/S1470-2045(08)70235-3","journal-title":"Lancet Oncol"},{"issue":"3","key":"8_CR40","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1200\/JCO.2004.04.181","volume":"22","author":"SJ Freedland","year":"2004","unstructured":"Freedland SJ, Aronson WJ, Kane CJ, Presti JC Jr, Amling CL, Elashoff D, Terris MK (2004) Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the shared equal access regional cancer hospital database study group. J Clin Oncol (Official Journal of the American Society of Clinical Oncology) 22(3):446\u2013453. doi: 10.1200\/JCO.2004.04.181","journal-title":"J Clin Oncol (Official Journal of the American Society of Clinical Oncology)"},{"issue":"3","key":"8_CR41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1200\/JCO.2004.03.132","volume":"22","author":"CL Amling","year":"2004","unstructured":"Amling CL, Riffenburgh RH, Sun L, Moul JW, Lance RS, Kusuda L, Sexton WJ, Soderdahl DW, Donahue TF, Foley JP, Chung AK, McLeod DG (2004) Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 22(3):439\u2013445","journal-title":"J Clin Oncol"},{"issue":"5","key":"8_CR42","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.eururo.2012.08.015","volume":"62","author":"T Ho","year":"2012","unstructured":"Ho T, Gerber L, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Freedland SJ (2012) Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database. Eur Urol 62(5):910\u2013916. doi: 10.1016\/j.eururo.2012.08.015","journal-title":"Eur Urol"},{"issue":"1","key":"8_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijrobp.2003.12.027","volume":"59","author":"LE Millender","year":"2004","unstructured":"Millender LE, Aubin M, Pouliot J, Shinohara K, Roach M 3rd (2004) Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 59(1):6\u201310. doi: 10.1016\/j.ijrobp.2003.12.027","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8_CR44","doi-asserted-by":"publisher","unstructured":"Freedland SJ, Terris MK, Presti JC Jr, Amling CL, Kane CJ, Trock B, Aronson WJ, Search Database Study G (2004) Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. J Urol 172(2):520\u2013524. doi: 10.1097\/01.ju.0000135302.58378.ae","DOI":"10.1097\/01.ju.0000135302.58378.ae"},{"key":"8_CR45","doi-asserted-by":"publisher","unstructured":"Davies NM, Gaunt TR, Lewis SJ, Holly J, Donovan JL, Hamdy FC, Kemp JP, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, consortium P, Lathrop M, Smith GD, Martin RM (2015) The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. Cancer Causes Control (CCC) 26(11):1603\u20131616. doi: 10.1007\/s10552-015-0654-9","DOI":"10.1007\/s10552-015-0654-9"},{"issue":"4","key":"8_CR46","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1172\/JCI10842","volume":"106","author":"BB Kahn","year":"2000","unstructured":"Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Investig 106(4):473\u2013481. doi: 10.1172\/JCI10842","journal-title":"J Clin Investig"},{"issue":"10","key":"8_CR47","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/jnci\/93.10.783","volume":"93","author":"AW Hsing","year":"2001","unstructured":"Hsing AW, Chua S Jr, Gao YT, Gentzschein E, Chang L, Deng J, Stanczyk FZ (2001) Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 93(10):783\u2013789","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"8_CR48","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/jnci\/djp260","volume":"101","author":"D Albanes","year":"2009","unstructured":"Albanes D, Weinstein SJ, Wright ME, Mannisto S, Limburg PJ, Snyder K, Virtamo J (2009) Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J Natl Cancer Inst 101(18):1272\u20131279. doi: 10.1093\/jnci\/djp260","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"8_CR49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.urology.2003.09.060","volume":"63","author":"JS Hubbard","year":"2004","unstructured":"Hubbard JS, Rohrmann S, Landis PK, Metter EJ, Muller DC, Andres R, Carter HB, Platz EA (2004) Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging. Urology 63(2):253\u2013258. doi: 10.1016\/j.urology.2003.09.060","journal-title":"Urology"},{"issue":"1","key":"8_CR50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/cncr.20727","volume":"103","author":"C Chen","year":"2005","unstructured":"Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS (2005) Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin. Cancer 103(1):76\u201384. doi: 10.1002\/cncr.20727","journal-title":"Cancer"},{"issue":"23","key":"8_CR51","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/jnci\/92.23.1910","volume":"92","author":"P Stattin","year":"2000","unstructured":"Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R (2000) Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92(23):1910\u20131917","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"8_CR52","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10552-014-0369-3","volume":"25","author":"GY Lai","year":"2014","unstructured":"Lai GY, Giovannucci EL, Pollak MN, Peskoe SB, Stampfer MJ, Willett WC, Platz EA (2014) Association of C-peptide and leptin with prostate cancer incidence in the health professionals follow-up study. Cancer Causes Control (CCC) 25(5):625\u2013632. doi: 10.1007\/s10552-014-0369-3","journal-title":"Cancer Causes Control (CCC)"},{"issue":"12","key":"8_CR53","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1002\/ijc.22587","volume":"120","author":"T Stocks","year":"2007","unstructured":"Stocks T, Lukanova A, Rinaldi S, Biessy C, Dossus L, Lindahl B, Hallmans G, Kaaks R, Stattin P (2007) Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden. Int J Cancer J Int Cancer 120(12):2678\u20132686. doi: 10.1002\/ijc.22587","journal-title":"Int J Cancer J Int Cancer"},{"issue":"10","key":"8_CR54","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1158\/1055-9965.EPI-07-0495","volume":"16","author":"MJ Borugian","year":"2007","unstructured":"Borugian MJ, Spinelli JJ, Sun Z, Kolonel LN, Oakley-Girvan I, Pollak MD, Whittemore AS, Wu AH, Gallagher RP (2007) Prediagnostic C-peptide and risk of prostate cancer. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 16(10):2164\u20132165. doi: 10.1158\/1055-9965.EPI-07-0495","journal-title":"Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)"},{"issue":"11","key":"8_CR55","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/sj.ijo.0803324","volume":"30","author":"IT Gram","year":"2006","unstructured":"Gram IT, Norat T, Rinaldi S, Dossus L, Lukanova A, Tehard B, Clavel-Chapelon F, van Gils CH, van Noord PA, Peeters PH, Bueno-de-Mesquita HB, Nagel G, Linseisen J, Lahmann PH, Boeing H, Palli D, Sacerdote C, Panico S, Tumino R, Sieri S, Dorronsoro M, Quiros JR, Navarro CA, Barricarte A, Tormo MJ, Gonzalez CA, Overvad K, Paaske Johnsen S, Olsen A, Tjonneland A, Travis R, Allen N, Bingham S, Khaw KT, Stattin P, Trichopoulou A, Kalapothaki V, Psaltopoulou T, Casagrande C, Riboli E, Kaaks R (2006) Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. Int J Obes 30(11):1623\u20131631. doi: 10.1038\/sj.ijo.0803324","journal-title":"Int J Obes"},{"issue":"5","key":"8_CR56","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.ijo.0800412","volume":"21","author":"SY Nam","year":"1997","unstructured":"Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB (1997) Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord (Journal of the International Association for the Study of Obesity) 21(5):355\u2013359","journal-title":"Int J Obes Relat Metab Disord (Journal of the International Association for the Study of Obesity)"},{"issue":"2","key":"8_CR57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/eje.0.1500161","volume":"150","author":"A Lukanova","year":"2004","unstructured":"Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P, Shore RE, Krogh V, Koenig KL, Riboli E, Berrino F, Hallmans G, Stattin P, Toniolo P, Kaaks R (2004) Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol\/Eur Fed Endocr Soc 150(2):161\u2013171","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"issue":"8","key":"8_CR58","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1210\/jc.2009-0614","volume":"94","author":"J Frystyk","year":"2009","unstructured":"Frystyk J, Brick DJ, Gerweck AV, Utz AL, Miller KK (2009) Bioactive insulin-like growth factor-I in obesity. J Clin Endocrinol Metab 94(8):3093\u20133097. doi: 10.1210\/jc.2009-0614","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"8_CR59","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1002\/ijc.24202","volume":"124","author":"MA Rowlands","year":"2009","unstructured":"Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM (2009) Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer J Int Cancer 124(10):2416\u20132429. doi: 10.1002\/ijc.24202","journal-title":"Int J Cancer J Int Cancer"},{"key":"8_CR60","doi-asserted-by":"crossref","unstructured":"Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, Hsing AW, Lacey JV Jr, Helzlsouer K, Rinaldi S, Riboli E, Kaaks R, Janssen JA, Wildhagen MF, Schroder FH, Platz EA, Pollak M, Giovannucci E, Schaefer C, Quesenberry CP Jr, Vogelman JH, Severi G, English DR, Giles GG, Stattin P, Hallmans G, Johansson M, Chan JM, Gann P, Oliver SE, Holly JM, Donovan J, Meyer F, Bairati I, Galan P (2008) Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149(7):461\u2013471, W483\u2013W468","DOI":"10.7326\/0003-4819-149-7-200810070-00006"},{"issue":"9","key":"8_CR61","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1158\/1055-9965.EPI-12-0481-T","volume":"21","author":"AJ Price","year":"2012","unstructured":"Price AJ, Allen NE, Appleby PN, Crowe FL, Travis RC, Tipper SJ, Overvad K, Gronbaek H, Tjonneland A, Johnsen NF, Rinaldi S, Kaaks R, Lukanova A, Boeing H, Aleksandrova K, Trichopoulou A, Trichopoulos D, Andarakis G, Palli D, Krogh V, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Arguelles MV, Sanchez MJ, Chirlaque MD, Barricarte A, Larranaga N, Gonzalez CA, Stattin P, Johansson M, Khaw KT, Wareham N, Gunter M, Riboli E, Key T (2012) Insulin-like growth factor-I concentration and risk of prostate cancer: results from the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 21(9):1531\u20131541. doi: 10.1158\/1055-9965.EPI-12-0481-T","journal-title":"Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)"},{"issue":"10","key":"8_CR62","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1002\/ijc.29295","volume":"136","author":"Y Cao","year":"2015","unstructured":"Cao Y, Nimptsch K, Shui IM, Platz EA, Wu K, Pollak MN, Kenfield SA, Stampfer MJ, Giovannucci EL (2015) Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer. Int J Cancer J Int Cancer 136(10):2418\u20132426. doi: 10.1002\/ijc.29295","journal-title":"Int J Cancer J Int Cancer"},{"issue":"3","key":"8_CR63","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/ijc.25381","volume":"128","author":"K Nimptsch","year":"2011","unstructured":"Nimptsch K, Platz EA, Pollak MN, Kenfield SA, Stampfer MJ, Willett WC, Giovannucci E (2011) Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the health professionals follow-up study 1993\u20132004. Int J Cancer J Int Cancer 128(3):660\u2013667. doi: 10.1002\/ijc.25381","journal-title":"Int J Cancer J Int Cancer"},{"issue":"5","key":"8_CR64","first-page":"421","volume":"10","author":"AP Chokkalingam","year":"2001","unstructured":"Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF Jr, Hsing AW (2001) Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 10(5):421\u2013427","journal-title":"Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)"},{"issue":"3","key":"8_CR65","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa030660","volume":"349","author":"IM Thompson","year":"2003","unstructured":"Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA Jr (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349(3):215\u2013224. doi: 10.1056\/NEJMoa030660","journal-title":"N Engl J Med"},{"issue":"8","key":"8_CR66","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1001\/jamainternmed.2014.1600","volume":"174","author":"MA Preston","year":"2014","unstructured":"Preston MA, Wilson KM, Markt SC, Ge R, Morash C, Stampfer MJ, Loda M, Giovannucci E, Mucci LA, Olumi AF (2014) 5alpha-Reductase inhibitors and risk of high-grade or lethal prostate cancer. JAMA Intern Med 174(8):1301\u20131307. doi: 10.1001\/jamainternmed.2014.1600","journal-title":"JAMA Intern Med"},{"issue":"1","key":"8_CR67","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1158\/1055-9965.EPI-05-0633","volume":"15","author":"G Severi","year":"2006","unstructured":"Severi G, Morris HA, MacInnis RJ, English DR, Tilley W, Hopper JL, Boyle P, Giles GG (2006) Circulating steroid hormones and the risk of prostate cancer. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 15(1):86\u201391. doi: 10.1158\/1055-9965.EPI-05-0633","journal-title":"Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)"},{"issue":"5","key":"8_CR68","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1158\/1055-9965.EPI-04-0371","volume":"14","author":"EA Platz","year":"2005","unstructured":"Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E (2005) Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 14(5):1262\u20131269. doi: 10.1158\/1055-9965.EPI-04-0371","journal-title":"Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)"},{"issue":"3","key":"8_CR69","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/jnci\/djm323","volume":"100","author":"H Endogenous","year":"2008","unstructured":"Endogenous H, Prostate Cancer Collaborative G, Roddam AW, Allen NE, Appleby P, Key TJ (2008) Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 100(3):170\u2013183. doi: 10.1093\/jnci\/djm323","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 2","key":"8_CR70","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1038\/sj.ijo.0801281","volume":"24","author":"A Hautanen","year":"2000","unstructured":"Hautanen A (2000) Synthesis and regulation of sex hormone-binding globulin in obesity. Int J Obes Relat Metabol Disord (Journal of the International Association for the Study of Obesity) 24(Suppl 2):S64\u2013S70","journal-title":"Int J Obes Relat Metabol Disord (Journal of the International Association for the Study of Obesity)"},{"issue":"1","key":"8_CR71","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/pros.1046","volume":"47","author":"G Schatzl","year":"2001","unstructured":"Schatzl G, Madersbacher S, Thurridl T, Waldmuller J, Kramer G, Haitel A, Marberger M (2001) High-grade prostate cancer is associated with low serum testosterone levels. Prostate 47(1):52\u201358. doi: 10.1002\/pros.1046","journal-title":"Prostate"},{"issue":"6","key":"8_CR72","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1097\/01.ju.0000158040.33531.e7","volume":"173","author":"G Isom-Batz","year":"2005","unstructured":"Isom-Batz G, Bianco FJ Jr, Kattan MW, Mulhall JP, Lilja H, Eastham JA (2005) Testosterone as a predictor of pathological stage in clinically localized prostate cancer. J Urol 173(6):1935\u20131937. doi: 10.1097\/01.ju.0000158040.33531.e7","journal-title":"J Urol"},{"issue":"5","key":"8_CR73","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1097\/01.ju.0000062674.43964.d0","volume":"169","author":"JC Massengill","year":"2003","unstructured":"Massengill JC, Sun L, Moul JW, Wu H, McLeod DG, Amling C, Lance R, Foley J, Sexton W, Kusuda L, Chung A, Soderdahl D, Donahue T (2003) Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol 169(5):1670\u20131675. doi: 10.1097\/01.ju.0000062674.43964.d0","journal-title":"J Urol"},{"issue":"5","key":"8_CR74","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1001\/jama.1991.03460050072023","volume":"265","author":"GW Chodak","year":"1991","unstructured":"Chodak GW, Vogelzang NJ, Caplan RJ, Soloway M, Smith JA (1991) Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group. JAMA 265(5):618\u2013621","journal-title":"JAMA"},{"issue":"6","key":"8_CR75","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00000421-199712000-00015","volume":"20","author":"M Ribeiro","year":"1997","unstructured":"Ribeiro M, Ruff P, Falkson G (1997) Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer. Am J Clin Oncol 20(6):605\u2013608","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"8_CR76","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.eururo.2013.01.003","volume":"65","author":"B Gershman","year":"2014","unstructured":"Gershman B, Shui IM, Stampfer M, Platz EA, Gann PH, Sesso HL, DuPre N, Giovannucci E, Mucci LA (2014) Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer. Eur Urol 65(4):683\u2013689. doi: 10.1016\/j.eururo.2013.01.003","journal-title":"Eur Urol"},{"issue":"11","key":"8_CR77","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1158\/1055-9965.EPI-06-0410","volume":"15","author":"JS Kasper","year":"2006","unstructured":"Kasper JS, Giovannucci E (2006) A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 15(11):2056\u20132062. doi: 10.1158\/1055-9965.EPI-06-0410","journal-title":"Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)"},{"issue":"4","key":"8_CR78","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/dmrr.2582","volume":"31","author":"H Cai","year":"2015","unstructured":"Cai H, Xu Z, Xu T, Yu B, Zou Q (2015) Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies. Diabetes\/Metab Res Rev 31(4):336\u2013343. doi: 10.1002\/dmrr.2582","journal-title":"Diabetes\/Metab Res Rev"},{"issue":"5748","key":"8_CR79","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.1117679","volume":"310","author":"SA Tomlins","year":"2005","unstructured":"Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310(5748):644\u2013648. doi: 10.1126\/science.1117679","journal-title":"Science"},{"issue":"24","key":"8_CR80","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1093\/jnci\/djt332","volume":"105","author":"A Pettersson","year":"2013","unstructured":"Pettersson A, Lis RT, Meisner A, Flavin R, Stack EC, Fiorentino M, Finn S, Graff RE, Penney KL, Rider JR, Nuttall EJ, Martin NE, Sesso HD, Pollak M, Stampfer MJ, Kantoff PW, Giovannucci EL, Loda M, Mucci LA (2013) Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG. J Natl Cancer Inst 105(24):1881\u20131890. doi: 10.1093\/jnci\/djt332","journal-title":"J Natl Cancer Inst"},{"issue":"1A","key":"8_CR81","first-page":"27","volume":"27","author":"DA Hunt","year":"2007","unstructured":"Hunt DA, Lane HM, Zygmont ME, Dervan PA, Hennigar RA (2007) MRNA stability and overexpression of fatty acid synthase in human breast cancer cell lines. Anticancer Res 27(1A):27\u201334","journal-title":"Anticancer Res"},{"issue":"6","key":"8_CR82","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0046-8177(97)90177-5","volume":"28","author":"TS Gansler","year":"1997","unstructured":"Gansler TS, Hardman W 3rd, Hunt DA, Schaffel S, Hennigar RA (1997) Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 28(6):686\u2013692","journal-title":"Hum Pathol"},{"issue":"25","key":"8_CR83","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1200\/JCO.2009.27.0793","volume":"28","author":"PL Nguyen","year":"2010","unstructured":"Nguyen PL, Ma J, Chavarro JE, Freedman ML, Lis R, Fedele G, Fiore C, Qiu W, Fiorentino M, Finn S, Penney KL, Eisenstein A, Schumacher FR, Mucci LA, Stampfer MJ, Giovannucci E, Loda M (2010) Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. J Clin Oncol (Official Journal of the American Society of Clinical Oncology) 28(25):3958\u20133964. doi: 10.1200\/JCO.2009.27.0793","journal-title":"J Clin Oncol (Official Journal of the American Society of Clinical Oncology)"},{"issue":"3","key":"8_CR84","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10549-009-0347-8","volume":"118","author":"D Campa","year":"2009","unstructured":"Campa D, McKay J, Sinilnikova O, Husing A, Vogel U, Hansen RD, Overvad K, Witt PM, Clavel-Chapelon F, Boutron-Ruault MC, Chajes V, Rohrmann S, Chang-Claude J, Boeing H, Fisher E, Trichopoulou A, Trichopoulos D, Palli D, Villarini A, Sacerdote C, Mattiello A, Tumino R, Peeters PH, van Gils CH, Bas Bueno-de-Mesquita H, Lund E, Chirlaque MD, Sala N, Suarez LR, Barricarte A, Dorronsoro M, Sanchez MJ, Lenner P, Hallmans G, Tsilidis K, Bingham S, Khaw KT, Gallo V, Norat T, Riboli E, Rinaldi S, Lenoir G, Tavtigian SV, Canzian F, Kaaks R (2009) Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk. Breast Cancer Res Treat 118(3):565\u2013574. doi: 10.1007\/s10549-009-0347-8","journal-title":"Breast Cancer Res Treat"}],"container-title":["Recent Results in Cancer Research","Obesity and Cancer"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-42542-9_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:26:14Z","timestamp":1568593574000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-42542-9_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319425405","9783319425429"],"references-count":84,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-42542-9_8","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}